Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gao, Lian Ru
WAIAMI, NCT04551443: WJMSCs Anti-inflammatory Therapy in Acute Myocardial Infarction	Not yet recruiting	2	200	NA	Intravenous infusion placebo, PBS, Intravenous infusion WJMSCs, WJMSCs	Navy General Hospital, Beijing, Peking University Third Hospital, Peking Union Medical College Hospital, Xijing Hospital, Chinese PLA General Hospital	Acute Myocardial Infarction	12/21	12/22
WANICHD, NCT04551456: WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease	Not yet recruiting	2	300	NA	Intravenous infusion human umbilical Wharton's jelly-derived mesenchymal stem Cell or placebo PBS, Intravenous infusion WJMSCs or placebo	Navy General Hospital, Beijing, Chinese PLA General Hospital, Peking University Third Hospital, Peking Union Medical College Hospital, Xijing Hospital	Coronary Artery Disease	12/21	12/22

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gao, Lian Ru
WAIAMI, NCT04551443: WJMSCs Anti-inflammatory Therapy in Acute Myocardial Infarction	Not yet recruiting	2	200	NA	Intravenous infusion placebo, PBS, Intravenous infusion WJMSCs, WJMSCs	Navy General Hospital, Beijing, Peking University Third Hospital, Peking Union Medical College Hospital, Xijing Hospital, Chinese PLA General Hospital	Acute Myocardial Infarction	12/21	12/22
WANICHD, NCT04551456: WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease	Not yet recruiting	2	300	NA	Intravenous infusion human umbilical Wharton's jelly-derived mesenchymal stem Cell or placebo PBS, Intravenous infusion WJMSCs or placebo	Navy General Hospital, Beijing, Chinese PLA General Hospital, Peking University Third Hospital, Peking Union Medical College Hospital, Xijing Hospital	Coronary Artery Disease	12/21	12/22